 non-aids-associ kaposi sarcoma classic endem african type treatment low dose recombin interferon-alpha treatment classic endem african form kaposi sarcoma KS radiat therapi chemotherapi degre success morbid preliminari experi low dose recombin interferon rifn treatment type KS non-link immunodefici syndrom aid consecut patient patient classic endem KS median age year long-term unit rifn introna time weekli month patient cutan diseas addit viscer involv month treatment patient major respons cutan lesion patient stabl skin diseas patient addit viscer diseas patient complet regress intramyocardi tumor right atrium ventricl wherea patient stabil viscer lesion mark symptomat improv whole long-term result median durat month rang satisfactori ifn-alpha KS patient treatment seriou side effect preliminari data low-dos rifn regimen effect classic endem african KS studi exact role ifn-alpha altern radiat chemotherapi